Sensata Technologies Holding PLC header image

Sensata Technologies Holding PLC

ST

Equity

ISIN GB00BFMBMT84 / Valor 40434003

New York Stock Exchange, Inc (2025-12-23)
USD 33.66-1.00%

Sensata Technologies Holding PLC
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Sensata Technologies Holding PLC is a global industrial technology company that designs and manufactures sensors and controls for a variety of industries.

Summarized from source with an LLMView SourceSector: Technology

Latest Results (21.11.2025):

This summary covers Sensata Technologies Holding PLC's fourth quarter of 2024 results. Sensata reported Q4 revenue of $907.7 million (down 8.5% year-over-year) and GAAP earnings per share of $0.04 (compared with a loss of $1.34 in Q4 2023). Adjusted operating income for Q4 was $174.9 million (19.3% of revenue) and adjusted EPS was $0.76. The company generated $138.9 million of free cash flow in the quarter and finished with $593.7 million of cash on hand; full-year 2024 free cash flow rose by over 40% versus the prior year.

Q4 Revenue and Profitability

Revenue: $907.7M (−8.5% vs Q4 2023). GAAP operating income: $73.8M (8.1% margin), a swing from a GAAP operating loss in Q4 2023. Adjusted operating income: $174.9M (19.3% of revenue), down 4.8% vs prior-year adjusted operating income.

Earnings Per Share

GAAP EPS: $0.04 (vs a loss per share of $1.34 in Q4 2023). Adjusted EPS: $0.76, down 6.2% from $0.81 in Q4 2023.

Cash Flow and Capital Returns

Q4 operating cash flow: $170.7M; Q4 free cash flow: $138.9M. End-of-quarter cash: $593.7M. In Q4 Sensata repurchased ~$21.6M of stock and paid $17.9M in dividends. For full-year 2024, free cash flow was $393.0M and share repurchases totaled ~$68.9M with $72.2M paid in dividends.

Full-Year 2024 Highlights

Revenue: $3,932.8M (−3.0% vs 2023). GAAP operating income: $149.3M (3.8% margin), down 17.8% YoY. Adjusted operating income: $748.5M (19.0% of revenue), down 3.3% YoY. GAAP EPS: $0.85 (vs loss of $0.03 in 2023). Adjusted EPS: $3.44, down 4.7% YoY.

Balance Sheet / Debt Actions

In July 2024 Sensata redeemed $700M of bonds due Oct 2025, funded by a $500M senior note issuance in June 2024 and ~ $200M cash on hand.

Outlook and Guidance (Q1 and Full Year 2025)

Q1 2025 guidance: Revenue $870–$890M; Adjusted operating income $158–$164M (adj. margin 18.2%–18.4%); Adjusted EPS $0.70–$0.73. Management expects full-year 2025 revenue to be organically flat with 2024 at ~ $3.6B after exiting ~ $300M of revenue in 2024, and expects adjusted operating margins to return to ~19.0% or better in Q2 and improve in H2. Guidance excludes potential impacts from proposed U.S. tariffs and retaliatory actions.

Summarized from source with an LLMView Source

Key figures

22.7%1Y
-15.4%3Y
-35.5%5Y

Performance

48.5%1Y
37.1%3Y
35.2%5Y

Volatility

Market cap

4904 M

Market cap (USD)

Daily traded volume (Shares)

805,993

Daily traded volume (Shares)

1 day high/low

27.34 / 26.65

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

MaxLinear Inc
MaxLinear Inc MaxLinear Inc Valor: 11132674
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.99%USD 17.69
Certara Inc
Certara Inc Certara Inc Valor: 58446660
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.54%USD 8.97
Veeco Instruments Inc
Veeco Instruments Inc Veeco Instruments Inc Valor: 325908
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.72%USD 29.58
Vera Therapeutics Inc
Vera Therapeutics Inc Vera Therapeutics Inc Valor: 111319498
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.24%USD 53.91
Astera Labs Inc
Astera Labs Inc Astera Labs Inc Valor: 133211877
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.20%USD 168.83
SpringWorks Therapeutics Inc
SpringWorks Therapeutics Inc SpringWorks Therapeutics Inc Valor: 49628191
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%USD 46.99
Atkinsrealis Group Inc
Atkinsrealis Group Inc Atkinsrealis Group Inc Valor: 135469111
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.17%CAD 90.09
RELIEF THERAPEUTICS Holding Ltd.
RELIEF THERAPEUTICS Holding Ltd. RELIEF THERAPEUTICS Holding Ltd. Valor: 125112599
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.83%CHF 2.26
WISeKey International Holding Ltd
WISeKey International Holding Ltd WISeKey International Holding Ltd Valor: 127606275
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.11%CHF 14.56
Softing AG
Softing AG Softing AG Valor: 1080222
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 2.62